Clinical Trial Update: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/3 trial evaluating a gonadotropin-releasing hormone agonist combined with letrozole for obese patients with progestin-insensitive endometrial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia
• Endometrial Cancer

Drugs mentioned

• Gonadotropin-releasing hormone agonist
• Letrozole (letrozole)

Snippet

Sponsor: Xiaojun Chen | Conditions: Endometrial Neoplasms, Atypical Endometrial Hyperplasia | Phase 2, Phase 3 | Status: RECRUITING